Cargando…

Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?

Fecal calprotectin (FC) is a biomarker for inflammation in inflammatory bowel disease (IBD). Interpretation of results can be complicated because of the use of different assays to determine FC. GOALS: To assess the agreement between 2 different assays for determining FC in patients with IBD. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Wassenaer, Elsa A., Diederen, Kay, van Leeuwen, Ester M.M., D’Haens, Geert R., Benninga, Marc A., Koot, Bart G.P., Kindermann, Angelika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Online Articles: Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647699/ https://www.ncbi.nlm.nih.gov/pubmed/33116067 http://dx.doi.org/10.1097/MCG.0000000000001460

Ejemplares similares

Diagnostic Accuracy of Transabdominal Ultrasound in Detecting Intestinal Inflammation in Paediatric IBD Patients—a Systematic Review
por: van Wassenaer, Elsa A, et al.
Publicado: (2019)

Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease: Promising, but Work in Progress
por: van Wassenaer, Elsa A, et al.
Publicado: (2021)

Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023)

Next-Generation Therapeutics for IBD
por: Löwenberg, Mark, et al.
Publicado: (2015)

Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example
por: Holtman, Gea A, et al.
Publicado: (2013)

Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices
por: van Wassenaer, Elsa A, et al.
Publicado: (2022)

Bowel ultrasound measurements in healthy children — systematic review and meta-analysis
por: van Wassenaer, Elsa A., et al.
Publicado: (2019)

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results
por: Kyle, Barry D, et al.
Publicado: (2020)

Intestinal Ultrasound to Evaluate Treatment Response During Pregnancy in Patients With Inflammatory Bowel Disease
por: De Voogd, Floris, et al.
Publicado: (2021)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
por: Bodelier, Alexander G. L., et al.
Publicado: (2016)

The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms
por: Frigerio, Sofía, et al.
Publicado: (2021)

Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019)

Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project
por: Fenton, David, et al.
Publicado: (2022)

Calprotectin instability may lead to undertreatment in children with IBD
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2020)

Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
por: Sharbatdaran, Majid, et al.
Publicado: (2018)

Engineered calprotectin-sensing probiotics for IBD surveillance in humans
por: Xia, Jonathan Y., et al.
Publicado: (2023)

The child’s perception on monitoring inflammatory bowel disease activity
por: van Wassenaer, Elsa A., et al.
Publicado: (2021)

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting
por: Volkers, Adriaan, et al.
Publicado: (2023)

The current status of non-radiologist-performed abdominal ultrasonography in paediatrics – a scoping literature review protocol
por: van Wassenaer, Elsa A., et al.
Publicado: (2019)

Non-radiologist-performed abdominal point-of-care ultrasonography in paediatrics — a scoping review
por: van Wassenaer, Elsa A., et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

The role of fecal calprotectin in pediatric disease
por: Jeong, Su Jin
Publicado: (2019)

What calprotectin cut-offs should apply for IBD in general practice?
por: Landis, Darryl, et al.
Publicado: (2016)

Fecal calprotectin in healthy children aged 4–16 years
por: Roca, María, et al.
Publicado: (2020)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Systematic review on fecal calprotectin in cystic fibrosis
por: Lazzarotto, Eduarda Sampaio, et al.
Publicado: (2022)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

Case report of cheilitis granulomatosa and joint complaints as presentation of Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

A prospective study comparing patient-reported outcomes in Crohn’s disease
por: Hoekman, Daniël R., et al.
Publicado: (2020)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak.
por: Younes, Cherradi
Publicado: (2020)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013)

A Study of Fecal Calprotectin in Obese Children and Adults
por: Park, Shin Young, et al.
Publicado: (2018)

Enteric Dysbiosis and Fecal Calprotectin Expression in Premature Infants
por: Ho, Thao T. B., et al.
Publicado: (2018)

COVID-19 and intestinal inflammation: Role of fecal calprotectin
por: Ojetti, Veronica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hgiib2ri9jp30il16oj0nvrcvk